3 Penny Stocks Insiders Are Buying: DiaMedica Therapeutics, Troika Media And More - DiaMedica Therapeutic

U.S. stock futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3

Troika Media

The Trade: Troika Media Group, Inc. (NASDAQ:TRKA) 10% owner Peter Coates acquired a total of 500,000 shares at an average price of $0.80. To acquire these shares, it cost around $398.05 thousand.
What’s Happening: Troika Media Group's subsidiary Converge Direct, LLC reported FY21 sales of $294 million.
What Troika Media Does: Troika Media Group Inc is a global marketing service company.

DiaMedica Therapeutics

The Trade: DiaMedica Therapeutics Inc. (NASDAQ:DMAC) 10% owner TomEnterprise AB acquired a total of 207,974 shares at an average price of $1.33. The insider spent around $275.9 thousand to buy those shares.
What’s Happening: DiaMedica Therapeutics recently announced the FDA has placed a clinical hold on its Phase 2/3 ReMEDy2 trial for DM199.
What DiaMedica Therapeutics Does: DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company.

Bitcoin, Ethereum Record Losses, Here Are The Top Crypto Movers For Thursday

Don’t forget to check out our premarket coverage here .

BitNile Holdings

The Trade: BitNile Holdings, Inc. (NYSE:NILE) Executive Chairman Milton C. Ault III acquired a total of 130,000 shares at an average price of $0.39. To acquire these shares, it cost around $50.22 thousand.
What’s Happening: BitNile's subsidiary, TurnOnGreen, was recently awarded State, Federal, and Utility certifications for its electric vehicle chargers.
What BitNile Holdings Does: BitNile Holdings Inc is a diversified holding company owning subsidiaries engaged in commercial and defence solutions, commercial lending, and data centre operations in North America, Europe, the Middle East, and internationally.

DMACDiaMedica Therapeutics Inc

$6.28-0.63%

Overview

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.